Oxurion Competitors and Similar CompaniesClear all
Alnylam's competitors and similar companies include ANI Pharmaceuticals.
 Alnylam Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments. |  ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. | |
Founding Date | Founding Date 2002 | Founding Date 1996 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Baudette, US HQ Oakville, CA Baudette, US | |
Employees | Employees 1,32324% increase | Employees 33813% increase |
Valuation ($) | Valuation ($) 36.5 b | Valuation ($) 1.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $3.7b (FY, 2025) | Revenue (est.) $883.4m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ANI Pharmaceuticals
HQ
Baudette, US
Employees
338↑ 13% increase
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
View company